A safe coronavirus 2019 disease (COVID-19) vaccine that can be administered to most of the pediatric population is a necessity for ending the pandemic, but trials for younger children have not occurred. The president of the American Academy of Pediatrics (AAP) wrote to key COVID-19 officials about the need to change this.
The lockdowns caused by the pandemic have led to many potential negative effects on children. An investigation looks into how they’ve impacted the exposure to spoken language for children with cochlear implants.
With the authorization of 2 vaccines in late 2020 it seemed like a corner had been turned with the pandemic. A recent poll offers insight into how the public feels like the pandemic is going and when the disruptions caused by it might end.
As the 2020-2021 influenza season loomed, many in health care worried that the seasonal disease would add to the extraordinary burden of coronavirus disease 2019 and create a perfect storm. Have various prevention strategies helped prevent this potential issue?
For our second episode in the series, we sat down with Candice Jones, MD, who is a board-certified general pediatrician in group practice in Orlando, Florida. She is also a former National Health Service Corps Scholar.
In 2006 the American Academy of Pediatrics issued guidance urging providers to not use nonrecommended tests and treatments for bronchiolitis. Further guidance in 2014 offered further clarification. An investigation examines whether the guidance led to better outcomes.
As technology and the role that clinicians have with running the practice have changed, so have the needs for practice management. Andrew J. Schuman, MD, FAAP, shares his guidance for practice management.